FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

Check out our latest news

Sysmex otwiera Technopark East Site-bazę odczynników do diagnostyki biologicznej. Sysmex als Top-Arbeitgeber Mittelstand 2019 ausgezeichnet Sysmex Europe GmbH was awarded as ‘Top Employer SME 2019’ and ranked 8th in the category ‘Electronics and Electrical Engineering, Medical Devices’ Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base Sysmex Obtains CE Certification for Automated Hematology Analyzer XN-31, Which Has an Automatic Measurement Function for Red Blood Cells Infected by Malaria Parasites First Advanced Clinical Parameter Haematology Workshop Vorstellung der neuen Klinischen Flowzytometrie-Lösung von Sysmex Sysmex to Be Special Sponsor of the Kobe Marathon 2019 29 января (вторник) состоялся семинар для врачей-лаборантов на базе Вологодской областной детской клинической больницы. Sysmex UK Ltd Brexit BCP Sysmex Europe GmbH organises a blood donation and sport event on 3 December With a View to New Value Creation, Sysmex Launches a Research Assay Service for HDL Function Measurement Blutspendeaktion bei Sysmex – 70 Blutspende-Helden zum 50. Firmenjubiläum Sysmex Launches Revohem FIX Chromogenic, a Blood Coagulation Factor IX Measurement Kit Sysmex Launches their First Subsidiary in Egypt and North Africa Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization CALiaGold – The new quantitative immunoassay from Sentinel Diagnostics for calprotectin measurement in SENTiFIT 270 Analyser
Enjoy our Media Center
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
SUSPECTED HUS IN ROUTINE ANALYSIS
See the Podcast